CD8A and neoplasm: This suggests that activated CD8+ T cells in cluster L0, which express the immune inhibitory checkpoint molecules Tim3 (Havcr2) and Lag3, and which are enriched in transplant but not primary tumors, may mediate transplant tumor cure by anti-PD-1 therapy.